Overview
Status
Active
Registry date
2020-01-15
Share capital
10,000.00 PLN
Registered address
23, 78-300 Niemierzyno, Poland
Email
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 296 days for 2023).
- 2025not filed
- 202411/07/2025
- 202307/05/2025
- 202226/04/2023
- 202126/04/2023
- 202022/06/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Hubert Piotr Czarny – President of the Management Board
Manner of representation
In the case of a multi-member management board, each member of the management board is authorized independently to incur obligations, represent the company and make declarations on its behalf.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ines Czarnaage 34 | 50 | $1,350.62 | 50% |
Hubert Piotr Czarnyage 36 | 50 | $1,350.62 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-09-22 | Address change (7, 78-300, Niemierzyno → 23, 78-300, Niemierzyno) | |
| 2020-01-15 | Entered in the register |
FAQ
The main business activity of Ecopharma focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 15, 2020.
The headquarters is located at: 23, 78-300 Niemierzyno.
The management board consists of: Hubert Piotr Czarny (President of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-17